Simplifying the complexity of diagnosing cancer
Despite the rapid advancement in breast imaging modalities, the current clinical pathway is inefficient, resulting in multiple procedures, inconclusive results, and a negative patient experience.
Imagio® represents the first real alternative to this complexity by providing diagnostic confidence earlier in the care pathway.
We all want faster answers for patients.
No one ever wants to miss a cancer.
Meet a new imaging modality
Imagio® uses non-invasive laser light and sound to display real-time images of functional and anatomic features that differentiate malignant tissue. Combined with our proprietary SenoGram® AI decision support, radiologists can classify the likelihood of malignancy with more precision and accuracy.
Benefits for:
See Benefits for:
Radiologists
Radiologists
- Earlier diagnosis of malignancy
- Confidence that you’re not missing a cancer
- Down-classifying BI-RADS on baseline
Staff
Staff
- Greater practice efficiency from fewer diagnostic workups
- Clinical decision support at point-of-care
- Reduces scheduling overload
Patients
Patients
- Reduced stress, worry, and wait-times
- Reduces negative biopsies
- Non-invasive and no ionizing radiation
Healthcare Systems
Healthcare Systems
- Less stress on overburdened staff
- Reduced patient wait times
- Improved profitability
A simple transition
Incorporating Imagio® into your workflow is similar to how you implemented tomosynthesis into your practice and includes training from one of the world’s leading breast ultrasound instructors.
Learn more See ROI example
A relief for patients
Studies show that the stress of waiting for biopsy results is indistinguishable from the same stress felt by patients actually diagnosed with cancer.
View patient site See patient scan
Our nationwide roadshow can bring Imagio® to your facility or you can start the conversation with a Seno rep today to get more details.
References
- Vlahiotis A, Griffin B, Stavros AT, Margolis J. Analysis of Utilization Patterns and Associated Costs of the Breast Imaging and Diagnostic Procedures After Screening Mammography. ClinicoEconomics and Outcomes Research 2018:10 157-167.
- Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, Kan L, Mirsky D, Sabine MJ, McGilly R, Caines JS. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ. 2001 Aug 7;165(3):277-83. PMID: 11517642; PMCID: PMC81326.
- NCI-funded Breast Cancer Surveillance Consortium (HHSN261201100031C). Downloaded from the Breast Cancer Surveillance Consortium Web site – https://bcsc-research.org/. Accessed January 23, 2017.